Dokkyo Medical Journal
Online ISSN : 2436-522X
Print ISSN : 2436-5211
Case Reports
A Case of Inflammatory Demyelinating Disease of the Central Nervous System Presenting with Clinical Manifestation of Multiple Sclerosis Following SARS-CoV-2 mRNA Vaccination
Yuta KatoHiroyuki OnoueGo ShimadaKyoko NumahataTomohiro OgawaYasuhiro AkaiwaTomoyuki Miyamoto
Author information
JOURNAL OPEN ACCESS

2023 Volume 2 Issue 3 Pages 232-244

Details
Abstract

A 57-year-old woman presented with abnormal sensations and muscle weakness in the left upper and lower limbs and difficulty in walking four days after coronavirus disease 2019 (COVID-19) vaccination. The patient had deep sensation deficits and increased tendon reflexes in the left upper and lower limbs. Her head and cervical spinal cord magnetic resonance imaging showed a ring-shaped contrast-enhancing lesion. Cerebrospinal fluid examination showed a mildly elevated cell count, myelin basic protein, and IgG index, and positive oligoclonal bands. The patient was diagnosed as inflammatory demyelinating diseases of the central nervous system (IDDCNS) due to vaccination and was treated with pulse steroids. Her symptoms improved to a greater degree compared to previously reported cases of IDDCNS after COVID-19 vaccination. The disease course of this case was monophasic, but was more similar to multiple sclerosis than to acute disseminated encephalomyelitis (ADEM) according to their diagnostic criteria. Careful long-term observation is necessary because vaccination, as in this case, may lead to relapses in multiple sclerosis (MS) patients who have not received disease-modifying drugs.

Content from these authors
© 2023 Dokkyo Medical Society

This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top